Objectif
Determining the molecular basis of natural phenotypic variation, including inter-individual susceptibility to common diseases, is a central challenge of post-genome genetics. The rat is a leading model species for research in physiology, pharmacology and toxicology, and for the study of a wide range of common, genetically complex human diseases. Decades of exquisite phenotyping and detailed analyses in rat experimental crosses have led to localization of hundreds of quantitative trait loci (QTLs) contai ning genes that confer susceptibility to complex disease phenotypes. However in common with studies in other organisms, few genes underlying these genetically complex traits have as yet been identified. The availability of the rat genome sequence and g enome-scale technologies, along with the ability to clone fertile adult rats, has substantially advanced the potential for functional genomics research in the rat model. The European Rat Tools for Functional Genomics (EURATools) consortium draws together leading European researchers in rat genetics, pharmacology, toxicology, disease pathophysiology, and genome biology and informatics. The central aim of this project is the development of integrated genome tools that will generate knowledge which can be translated into improvements in healthcare for highly prevalent diseases in the European Union. The EURATools aims will be achieved by integrating high-throughput sequencing and genotyping with informatics; by intensive analysis of phenotypes, gene seq uence and gene expression in congenic strains to identify genes and regulatory pathways for a wide range of rat disease phenotypes; and by establishment of optimised protocols for rat gene targeting. These new resources will significantly improve our und erstanding of complex genetic traits, and will enhance prospects for drug development and strategies for preventing and treating some of the commonest diseases in western societies.
Champ scientifique
- medical and health sciencesbasic medicinepharmacology and pharmacydrug discovery
- medical and health sciencesclinical medicineendocrinologydiabetes
- medical and health sciencesbasic medicineimmunologyautoimmune diseases
- natural sciencesbiological sciencesgeneticsgenomes
- medical and health sciencesbasic medicinetoxicology
Appel à propositions
FP6-2004-LIFESCIHEALTH-5
Voir d’autres projets de cet appel
Régime de financement
IP - Integrated ProjectCoordinateur
Participants (16)
BRUSSELS
Voir sur la carte
PARIS
Voir sur la carte
OXFORD
Voir sur la carte
BELLATERRA (CERDANYOLA DEL VALLÈS)
Voir sur la carte
DUNDEE
Voir sur la carte